Every donation no matter the size helps us continue our effort in helping others. For sponsorship opportunities including in-kind donations please contact us. )
Takeda strives toward better health and a brighter future for people worldwide through leading innovation in medicine. We are committed to leading the way in plasma-derived therapies, which are a core part of our business and reflect our consistent, overarching values of integrity, fairness, honesty, and perseverance.
Takeda’s MyIgSource is committed to providing education and peer-to-peer support to help people manage life with primary immunodeficiency (PI). We invite you to join MyIgSource to connect with our Ig Community Support Team.
CSL Behring is a global biotechnology leader, driven by the promise to save and improve lives by offering the broadest range of quality plasma-derived and recombinant therapies in the industry.Click here to learn about a ready-to-infuse option for people living with PI. Discover a therapy for PI that simplifies the self-infusion process.
Since 1909, Grifols has worked to improve the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital, and Bio supplies - develop, produce, and market innovative solutions and services in more than 100 countries.
We invite you to learn more about our product, XEMBIFY, a subcutaneous immune globulin (SCIG) replacement therapy used to treat PI in patients 2 years of age and older by clicking here.
At Horizon Therapeutics we believe science and compassion must work together to transform lives. As part of our mission, we strive to improve the experience of living with a rare disease, including through the support of many organizations that provide crucial programs and services for people with chronic granulomatous disease (CGD) and other rare diseases.
Please click here to learn more about our dedication to people living with CGD.
Octapharma develops and produces high-quality human proteins from human plasma and human cell lines.
Please join our initiative, IgCares, a comprehensive primary immunodeficiency (PI) support program. It provides educations and treatment resources to PI patients and caregivers and benefits the PI community at large.
At Pfizer, we apply science & our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.